A detailed history of Health Invest Partners Ab transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Health Invest Partners Ab holds 20,199 shares of MORF stock, worth $1.15 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
20,199
Previous 14,952 35.09%
Holding current value
$1.15 Million
Previous $526,000 30.8%
% of portfolio
0.43%
Previous 0.33%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$26.12 - $34.07 $137,051 - $178,765
5,247 Added 35.09%
20,199 $688,000
Q4 2023

Jan 30, 2024

BUY
$19.95 - $31.0 $298,292 - $463,512
14,952 New
14,952 $431,000

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Health Invest Partners Ab Portfolio

Follow Health Invest Partners Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

News

Stay updated on Health Invest Partners Ab with notifications on news.